Inhibitors of Protein Synthesis
Start with the big picture
The lesson organizes inhibitors by their targets and effects. Aminoglycosides and tetracyclines act at the 30S subunit, while several important classes—including macrolides, clindamycin, linezolid, and chloramphenicol—target the 50S subunit. Their mechanisms include misreading mRNA, preventing tRNA attachment, blocking initiation, and inhibiting translocation or peptide-bond formation. Resistance mechanisms highlighted in the source include altered uptake or efflux and methylation of 23S rRNA. The topic also covers agents acting outside the main ribosomal-subunit groups, such as mupirocin, fusidic acid, and puromycin, alongside toxins that interrupt eukaryotic translation. Together, these examples show why identifying the molecular target is central to distinguishing drug actions and associated clinical considerations.
What you'll learn
- Distinguish the principal protein synthesis inhibitors by ribosomal target and mechanism.
- Describe resistance mechanisms associated with tetracyclines and 23S rRNA methylation.
- Identify notable clinical uses and adverse effects highlighted for selected inhibitors.
- Compare bacterial translation inhibitors with toxins that disrupt eukaryotic protein synthesis.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
